This report aims to provide a comprehensive presentation of the global market for NASH Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NASH Therapeutic Drugs. This report contains market size and forecasts of NASH Therapeutic Drugs in global, including the following market information:
Global NASH Therapeutic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global NASH Therapeutic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Vitamin E and Pioglitazone Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of NASH Therapeutic Drugs include Allergan Plc (Tobira), Bristol Myers Squibb, Galmed Pharmaceuticals, Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc. and Zydus Cadila, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the NASH Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NASH Therapeutic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global NASH Therapeutic Drugs Market Segment Percentages, by Type, 2022 (%)
Vitamin E and Pioglitazone
Ocaliva
Elafibranor
Selonsertib and Cenicriviroc
Global NASH Therapeutic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global NASH Therapeutic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Online Provider
Retail Pharmacy
Global NASH Therapeutic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global NASH Therapeutic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NASH Therapeutic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies NASH Therapeutic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc (Tobira)
Bristol Myers Squibb
Galmed Pharmaceuticals
Genfit SA
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Zydus Cadila
Outline of Major Chapters:
Chapter 1: Introduces the definition of NASH Therapeutic Drugs, market overview.
Chapter 2: Global NASH Therapeutic Drugs market size in revenue.
Chapter 3: Detailed analysis of NASH Therapeutic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NASH Therapeutic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 NASH Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NASH Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NASH Therapeutic Drugs Overall Market Size
2.1 Global NASH Therapeutic Drugs Market Size: 2022 VS 2030
2.2 Global NASH Therapeutic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NASH Therapeutic Drugs Players in Global Market
3.2 Top Global NASH Therapeutic Drugs Companies Ranked by Revenue
3.3 Global NASH Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 NASH Therapeutic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies NASH Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 NASH Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 NASH Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 NASH Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NASH Therapeutic Drugs Market Size Markets, 2022 & 2030
4.1.2 Vitamin E and Pioglitazone
4.1.3 Ocaliva
4.1.4 Elafibranor
4.1.5 Selonsertib and Cenicriviroc
4.2 By Type - Global NASH Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global NASH Therapeutic Drugs Revenue, 2018-2023
4.2.2 By Type - Global NASH Therapeutic Drugs Revenue, 2024-2030
4.2.3 By Type - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NASH Therapeutic Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Online Provider
5.1.4 Retail Pharmacy
5.2 By Application - Global NASH Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global NASH Therapeutic Drugs Revenue, 2018-2023
5.2.2 By Application - Global NASH Therapeutic Drugs Revenue, 2024-2030
5.2.3 By Application - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global NASH Therapeutic Drugs Market Size, 2022 & 2030
6.2 By Region - Global NASH Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global NASH Therapeutic Drugs Revenue, 2018-2023
6.2.2 By Region - Global NASH Therapeutic Drugs Revenue, 2024-2030
6.2.3 By Region - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America NASH Therapeutic Drugs Revenue, 2018-2030
6.3.2 US NASH Therapeutic Drugs Market Size, 2018-2030
6.3.3 Canada NASH Therapeutic Drugs Market Size, 2018-2030
6.3.4 Mexico NASH Therapeutic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe NASH Therapeutic Drugs Revenue, 2018-2030
6.4.2 Germany NASH Therapeutic Drugs Market Size, 2018-2030
6.4.3 France NASH Therapeutic Drugs Market Size, 2018-2030
6.4.4 U.K. NASH Therapeutic Drugs Market Size, 2018-2030
6.4.5 Italy NASH Therapeutic Drugs Market Size, 2018-2030
6.4.6 Russia NASH Therapeutic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries NASH Therapeutic Drugs Market Size, 2018-2030
6.4.8 Benelux NASH Therapeutic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia NASH Therapeutic Drugs Revenue, 2018-2030
6.5.2 China NASH Therapeutic Drugs Market Size, 2018-2030
6.5.3 Japan NASH Therapeutic Drugs Market Size, 2018-2030
6.5.4 South Korea NASH Therapeutic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia NASH Therapeutic Drugs Market Size, 2018-2030
6.5.6 India NASH Therapeutic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America NASH Therapeutic Drugs Revenue, 2018-2030
6.6.2 Brazil NASH Therapeutic Drugs Market Size, 2018-2030
6.6.3 Argentina NASH Therapeutic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NASH Therapeutic Drugs Revenue, 2018-2030
6.7.2 Turkey NASH Therapeutic Drugs Market Size, 2018-2030
6.7.3 Israel NASH Therapeutic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia NASH Therapeutic Drugs Market Size, 2018-2030
6.7.5 UAE NASH Therapeutic Drugs Market Size, 2018-2030
7 NASH Therapeutic Drugs Companies Profiles
7.1 Allergan Plc (Tobira)
7.1.1 Allergan Plc (Tobira) Company Summary
7.1.2 Allergan Plc (Tobira) Business Overview
7.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Major Product Offerings
7.1.4 Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue in Global Market (2018-2023)
7.1.5 Allergan Plc (Tobira) Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Company Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Major Product Offerings
7.2.4 Bristol Myers Squibb NASH Therapeutic Drugs Revenue in Global Market (2018-2023)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 Galmed Pharmaceuticals
7.3.1 Galmed Pharmaceuticals Company Summary
7.3.2 Galmed Pharmaceuticals Business Overview
7.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Major Product Offerings
7.3.4 Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue in Global Market (2018-2023)
7.3.5 Galmed Pharmaceuticals Key News & Latest Developments
7.4 Genfit SA
7.4.1 Genfit SA Company Summary
7.4.2 Genfit SA Business Overview
7.4.3 Genfit SA NASH Therapeutic Drugs Major Product Offerings
7.4.4 Genfit SA NASH Therapeutic Drugs Revenue in Global Market (2018-2023)
7.4.5 Genfit SA Key News & Latest Developments
7.5 Gilead Sciences, Inc.
7.5.1 Gilead Sciences, Inc. Company Summary
7.5.2 Gilead Sciences, Inc. Business Overview
7.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Major Product Offerings
7.5.4 Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue in Global Market (2018-2023)
7.5.5 Gilead Sciences, Inc. Key News & Latest Developments
7.6 Intercept Pharmaceuticals, Inc.
7.6.1 Intercept Pharmaceuticals, Inc. Company Summary
7.6.2 Intercept Pharmaceuticals, Inc. Business Overview
7.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Major Product Offerings
7.6.4 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue in Global Market (2018-2023)
7.6.5 Intercept Pharmaceuticals, Inc. Key News & Latest Developments
7.7 Zydus Cadila
7.7.1 Zydus Cadila Company Summary
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila NASH Therapeutic Drugs Major Product Offerings
7.7.4 Zydus Cadila NASH Therapeutic Drugs Revenue in Global Market (2018-2023)
7.7.5 Zydus Cadila Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. NASH Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. NASH Therapeutic Drugs Market Drivers in Global Market
Table 3. NASH Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of NASH Therapeutic Drugs in Global Market
Table 5. Top NASH Therapeutic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global NASH Therapeutic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global NASH Therapeutic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies NASH Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 NASH Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 NASH Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global NASH Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - NASH Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - NASH Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global NASH Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - NASH Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - NASH Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global NASH Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global NASH Therapeutic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global NASH Therapeutic Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America NASH Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe NASH Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia NASH Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America NASH Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa NASH Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Allergan Plc (Tobira) Company Summary
Table 31. Allergan Plc (Tobira) NASH Therapeutic Drugs Product Offerings
Table 32. Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Allergan Plc (Tobira) Key News & Latest Developments
Table 34. Bristol Myers Squibb Company Summary
Table 35. Bristol Myers Squibb NASH Therapeutic Drugs Product Offerings
Table 36. Bristol Myers Squibb NASH Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol Myers Squibb Key News & Latest Developments
Table 38. Galmed Pharmaceuticals Company Summary
Table 39. Galmed Pharmaceuticals NASH Therapeutic Drugs Product Offerings
Table 40. Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Galmed Pharmaceuticals Key News & Latest Developments
Table 42. Genfit SA Company Summary
Table 43. Genfit SA NASH Therapeutic Drugs Product Offerings
Table 44. Genfit SA NASH Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Genfit SA Key News & Latest Developments
Table 46. Gilead Sciences, Inc. Company Summary
Table 47. Gilead Sciences, Inc. NASH Therapeutic Drugs Product Offerings
Table 48. Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Gilead Sciences, Inc. Key News & Latest Developments
Table 50. Intercept Pharmaceuticals, Inc. Company Summary
Table 51. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product Offerings
Table 52. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Intercept Pharmaceuticals, Inc. Key News & Latest Developments
Table 54. Zydus Cadila Company Summary
Table 55. Zydus Cadila NASH Therapeutic Drugs Product Offerings
Table 56. Zydus Cadila NASH Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Zydus Cadila Key News & Latest Developments
List of Figures
Figure 1. NASH Therapeutic Drugs Segment by Type in 2022
Figure 2. NASH Therapeutic Drugs Segment by Application in 2022
Figure 3. Global NASH Therapeutic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global NASH Therapeutic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global NASH Therapeutic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2022
Figure 8. By Type - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global NASH Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global NASH Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 16. US NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 20. Germany NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 28. China NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa NASH Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE NASH Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Allergan Plc (Tobira) NASH Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol Myers Squibb NASH Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Galmed Pharmaceuticals NASH Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Genfit SA NASH Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Gilead Sciences, Inc. NASH Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Zydus Cadila NASH Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
